| 0 |
HYPOTHALAMIC OBESITY |
1 |
0.2500 |
| 1 |
ACUTE HAEMORRHAGIC CONJUNCTIVITIS |
1 |
0.0333 |
| 2 |
INTRACRANIAL TUMOUR HAEMORRHAGE |
10 |
0.0258 |
| 3 |
CUTIBACTERIUM ACNES INFECTION |
1 |
0.0169 |
| 4 |
HYPERFIBRINOGENAEMIA |
1 |
0.0149 |
| 5 |
EPHELIDES |
6 |
0.0111 |
| 6 |
HAEMODILUTION |
1 |
0.0101 |
| 7 |
MUCOCUTANEOUS TOXICITY |
1 |
0.0095 |
| 8 |
HERPES ZOSTER MENINGOENCEPHALITIS |
3 |
0.0083 |
| 9 |
PRODUCT GEL FORMATION |
1 |
0.0082 |
| 10 |
PNEUMOCOCCAL BACTERAEMIA |
1 |
0.0079 |
| 11 |
SUBARACHNOID HAEMATOMA |
1 |
0.0075 |
| 12 |
THYMUS ENLARGEMENT |
1 |
0.0063 |
| 13 |
TOXIC SHOCK SYNDROME STREPTOCOCCAL |
1 |
0.0052 |
| 14 |
HAEMORRHAGIC CYST |
2 |
0.0052 |
| 15 |
OCULAR ROSACEA |
1 |
0.0049 |
| 16 |
EYELASH DISCOLOURATION |
1 |
0.0046 |
| 17 |
PERIPHERAL VEIN THROMBOSIS |
1 |
0.0042 |
| 18 |
GROWTH RETARDATION |
12 |
0.0041 |
| 19 |
CREATINE KINASE INCREASED |
3 |
0.0039 |
| 20 |
THUNDERCLAP HEADACHE |
1 |
0.0038 |
| 21 |
CENTRAL PAIN SYNDROME |
1 |
0.0038 |
| 22 |
SHUNT MALFUNCTION |
1 |
0.0035 |
| 23 |
MELANOCYTIC NAEVUS |
15 |
0.0034 |
| 24 |
CEREBRAL ASPERGILLOSIS |
2 |
0.0033 |
| 25 |
CORNEAL INFILTRATES |
1 |
0.0032 |
| 26 |
CENTRAL HYPOTHYROIDISM |
1 |
0.0030 |
| 27 |
MYOSCLEROSIS |
1 |
0.0027 |
| 28 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
2 |
0.0022 |
| 29 |
CEREBRAL MICROHAEMORRHAGE |
1 |
0.0022 |
| 30 |
BLOOD PHOSPHORUS DECREASED |
8 |
0.0022 |
| 31 |
DISSEMINATED ASPERGILLOSIS |
1 |
0.0021 |
| 32 |
ELECTROCARDIOGRAM QT INTERVAL ABNORMAL |
1 |
0.0020 |
| 33 |
EXPULSION OF MEDICATION |
1 |
0.0019 |
| 34 |
TUMOUR HAEMORRHAGE |
5 |
0.0018 |
| 35 |
DERMATITIS ACNEIFORM |
10 |
0.0016 |
| 36 |
PNEUMONIA NECROTISING |
1 |
0.0015 |
| 37 |
CELLULITIS STAPHYLOCOCCAL |
1 |
0.0015 |
| 38 |
PNEUMOCOCCAL SEPSIS |
1 |
0.0015 |
| 39 |
CEREBRAL CYST |
1 |
0.0015 |
| 40 |
HAIR COLOUR CHANGES |
18 |
0.0014 |
| 41 |
ACCIDENTAL UNDERDOSE |
19 |
0.0013 |
| 42 |
RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS |
1 |
0.0013 |
| 43 |
HAND-FOOT-AND-MOUTH DISEASE |
1 |
0.0012 |
| 44 |
AMAUROSIS |
1 |
0.0012 |
| 45 |
PERIORBITAL PAIN |
1 |
0.0012 |
| 46 |
SKIN HYPOPIGMENTATION |
2 |
0.0011 |
| 47 |
STREPTOCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 48 |
TUMOUR PSEUDOPROGRESSION |
1 |
0.0009 |
| 49 |
METASTASES TO MENINGES |
2 |
0.0009 |
| 50 |
XEROSIS |
1 |
0.0008 |
| 51 |
OESOPHAGEAL HAEMORRHAGE |
1 |
0.0008 |
| 52 |
MACULE |
2 |
0.0007 |
| 53 |
PROTHROMBIN TIME SHORTENED |
1 |
0.0007 |
| 54 |
NAIL INFECTION |
1 |
0.0007 |
| 55 |
GINGIVAL HYPERTROPHY |
1 |
0.0007 |
| 56 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
1 |
0.0007 |
| 57 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 58 |
TYMPANIC MEMBRANE PERFORATION |
1 |
0.0006 |
| 59 |
HYPOPITUITARISM |
1 |
0.0006 |
| 60 |
MONOPARESIS |
1 |
0.0006 |
| 61 |
PHOTOSENSITIVITY REACTION |
9 |
0.0005 |
| 62 |
GRANULOCYTE COUNT DECREASED |
1 |
0.0005 |
| 63 |
HYPERAEMIA |
1 |
0.0005 |
| 64 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
1 |
0.0005 |
| 65 |
BLEPHARITIS |
2 |
0.0005 |
| 66 |
ALANINE AMINOTRANSFERASE ABNORMAL |
1 |
0.0005 |
| 67 |
BRAIN OPERATION |
1 |
0.0004 |
| 68 |
DIABETES INSIPIDUS |
1 |
0.0004 |
| 69 |
PANNICULITIS |
1 |
0.0004 |
| 70 |
HYPOPHOSPHATAEMIA |
3 |
0.0004 |
| 71 |
HEPATIC ENZYME ABNORMAL |
2 |
0.0004 |
| 72 |
PRODUCT SOLUBILITY ABNORMAL |
2 |
0.0004 |
| 73 |
MEAN CELL VOLUME INCREASED |
1 |
0.0004 |
| 74 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 75 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
11 |
0.0004 |
| 76 |
LARYNGOSPASM |
1 |
0.0004 |
| 77 |
PSYCHOMOTOR RETARDATION |
1 |
0.0004 |
| 78 |
SKIN TOXICITY |
2 |
0.0004 |
| 79 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 80 |
SKIN HYPERPIGMENTATION |
3 |
0.0003 |
| 81 |
RETINAL VEIN OCCLUSION |
1 |
0.0003 |
| 82 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 83 |
HAEMATOTOXICITY |
3 |
0.0003 |
| 84 |
CEREBRAL HAEMATOMA |
1 |
0.0003 |
| 85 |
B-CELL LYMPHOMA |
1 |
0.0003 |
| 86 |
AMENORRHOEA |
5 |
0.0003 |
| 87 |
FACIAL PARESIS |
1 |
0.0003 |
| 88 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 89 |
WOUND HAEMORRHAGE |
1 |
0.0003 |
| 90 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0002 |
| 91 |
DEMYELINATION |
1 |
0.0002 |
| 92 |
HYPERURICAEMIA |
1 |
0.0002 |
| 93 |
DISEASE PROGRESSION |
28 |
0.0002 |
| 94 |
HEPATIC CYTOLYSIS |
3 |
0.0002 |
| 95 |
ABSCESS LIMB |
1 |
0.0002 |
| 96 |
PRODUCT COMMUNICATION ISSUE |
2 |
0.0002 |
| 97 |
DEVICE OCCLUSION |
3 |
0.0002 |
| 98 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 99 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 100 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 101 |
HYPERBILIRUBINAEMIA |
2 |
0.0002 |
| 102 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 103 |
PRODUCT USE COMPLAINT |
3 |
0.0002 |
| 104 |
PHARYNGITIS STREPTOCOCCAL |
2 |
0.0002 |
| 105 |
SKIN LACERATION |
2 |
0.0002 |
| 106 |
HYDROCEPHALUS |
1 |
0.0002 |
| 107 |
NEUTROPHILIA |
1 |
0.0002 |
| 108 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 109 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 110 |
HYPERCALCAEMIA |
2 |
0.0002 |
| 111 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 112 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 113 |
BLOOD BILIRUBIN INCREASED |
4 |
0.0001 |
| 114 |
COORDINATION ABNORMAL |
2 |
0.0001 |
| 115 |
PAPULE |
1 |
0.0001 |
| 116 |
TONGUE DISORDER |
1 |
0.0001 |
| 117 |
ACNE |
10 |
0.0001 |
| 118 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 119 |
PERICARDIAL EFFUSION |
3 |
0.0001 |
| 120 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 121 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 122 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 123 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 124 |
EOSINOPHILIA |
2 |
0.0001 |
| 125 |
DRUG ERUPTION |
2 |
0.0001 |
| 126 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 127 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 128 |
LIP DRY |
1 |
0.0001 |
| 129 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 130 |
ATELECTASIS |
1 |
0.0001 |
| 131 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 132 |
PRODUCT PHYSICAL ISSUE |
2 |
0.0001 |
| 133 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 134 |
PETECHIAE |
1 |
0.0001 |
| 135 |
SCRATCH |
1 |
0.0001 |
| 136 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 137 |
ASPIRATION |
1 |
0.0001 |
| 138 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 139 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 140 |
LYMPHADENOPATHY |
3 |
0.0001 |
| 141 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 142 |
BACTERAEMIA |
1 |
0.0001 |
| 143 |
CYTOPENIA |
1 |
0.0001 |
| 144 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 145 |
BRAIN OEDEMA |
1 |
0.0001 |
| 146 |
MYDRIASIS |
1 |
0.0001 |
| 147 |
UVEITIS |
1 |
0.0001 |
| 148 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 149 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 150 |
OSTEOPENIA |
1 |
0.0001 |
| 151 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 152 |
NIGHT SWEATS |
2 |
0.0001 |
| 153 |
RASH |
27 |
0.0001 |
| 154 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 155 |
PSYCHOMOTOR HYPERACTIVITY |
1 |
0.0001 |
| 156 |
SKIN DISORDER |
2 |
0.0001 |
| 157 |
CELLULITIS |
3 |
0.0001 |
| 158 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 159 |
THIRST |
1 |
0.0001 |
| 160 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 161 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 162 |
EPISTAXIS |
4 |
0.0001 |
| 163 |
BLISTER |
3 |
0.0001 |
| 164 |
HYPONATRAEMIA |
3 |
0.0001 |
| 165 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 166 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 167 |
FEELING JITTERY |
1 |
0.0001 |
| 168 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 169 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 170 |
SPINAL FRACTURE |
1 |
0.0000 |
| 171 |
RIB FRACTURE |
1 |
0.0000 |
| 172 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 173 |
DERMATITIS |
1 |
0.0000 |
| 174 |
SWELLING FACE |
3 |
0.0000 |
| 175 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 176 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 177 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 178 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 179 |
RASH PAPULAR |
1 |
0.0000 |
| 180 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 181 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 182 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 183 |
AGEUSIA |
1 |
0.0000 |
| 184 |
LEUKOPENIA |
2 |
0.0000 |
| 185 |
HYPOPHAGIA |
1 |
0.0000 |
| 186 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 187 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 188 |
OFF LABEL USE |
34 |
0.0000 |
| 189 |
DIPLOPIA |
1 |
0.0000 |
| 190 |
ECZEMA |
2 |
0.0000 |
| 191 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 192 |
SEDATION |
1 |
0.0000 |
| 193 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 194 |
EAR INFECTION |
1 |
0.0000 |
| 195 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 196 |
JAUNDICE |
1 |
0.0000 |
| 197 |
PNEUMONITIS |
1 |
0.0000 |
| 198 |
ANAEMIA |
7 |
0.0000 |
| 199 |
HAEMOPTYSIS |
1 |
0.0000 |
| 200 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 201 |
HYPERSOMNIA |
1 |
0.0000 |
| 202 |
LETHARGY |
2 |
0.0000 |
| 203 |
SEIZURE |
4 |
0.0000 |
| 204 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 205 |
STOMATITIS |
2 |
0.0000 |
| 206 |
PLEURAL EFFUSION |
2 |
0.0000 |
| 207 |
EPILEPSY |
1 |
0.0000 |
| 208 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 209 |
CYSTITIS |
1 |
0.0000 |
| 210 |
MOOD SWINGS |
1 |
0.0000 |
| 211 |
IMPAIRED HEALING |
1 |
0.0000 |
| 212 |
URINARY RETENTION |
1 |
0.0000 |
| 213 |
EYE PRURITUS |
1 |
0.0000 |
| 214 |
FATIGUE |
23 |
0.0000 |
| 215 |
MYALGIA |
5 |
0.0000 |
| 216 |
HAEMATURIA |
1 |
0.0000 |
| 217 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 218 |
WEIGHT DECREASED |
8 |
0.0000 |
| 219 |
DEVICE MALFUNCTION |
2 |
0.0000 |
| 220 |
HYPOXIA |
1 |
0.0000 |
| 221 |
CONSTIPATION |
6 |
0.0000 |
| 222 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 223 |
AGITATION |
2 |
0.0000 |
| 224 |
HEADACHE |
17 |
0.0000 |
| 225 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 226 |
ERYTHEMA |
5 |
0.0000 |
| 227 |
POLLAKIURIA |
1 |
0.0000 |
| 228 |
BALANCE DISORDER |
2 |
0.0000 |
| 229 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 230 |
SEPTIC SHOCK |
1 |
0.0000 |
| 231 |
ANGIOEDEMA |
1 |
0.0000 |
| 232 |
DRY SKIN |
3 |
0.0000 |
| 233 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 234 |
THROAT IRRITATION |
1 |
0.0000 |
| 235 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 236 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 237 |
DECREASED APPETITE |
5 |
0.0000 |
| 238 |
SWELLING |
2 |
0.0000 |
| 239 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 240 |
CONTUSION |
2 |
0.0000 |
| 241 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 242 |
HEART RATE INCREASED |
2 |
0.0000 |
| 243 |
SOMNOLENCE |
4 |
0.0000 |
| 244 |
THERAPY CESSATION |
1 |
0.0000 |
| 245 |
NERVOUSNESS |
1 |
0.0000 |
| 246 |
HAEMORRHAGE |
2 |
0.0000 |
| 247 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 248 |
SPEECH DISORDER |
1 |
0.0000 |
| 249 |
INSOMNIA |
5 |
0.0000 |
| 250 |
RASH PRURITIC |
1 |
0.0000 |
| 251 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 252 |
ARTHROPATHY |
1 |
0.0000 |
| 253 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 254 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 255 |
EYE IRRITATION |
1 |
0.0000 |
| 256 |
SURGERY |
1 |
0.0000 |
| 257 |
IRRITABILITY |
1 |
0.0000 |
| 258 |
VERTIGO |
1 |
0.0000 |
| 259 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 260 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 261 |
AMNESIA |
1 |
0.0000 |
| 262 |
ALOPECIA |
3 |
0.0000 |
| 263 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 264 |
NAUSEA |
11 |
0.0000 |
| 265 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 266 |
UNDERDOSE |
1 |
0.0000 |
| 267 |
ASTHENIA |
5 |
0.0000 |
| 268 |
DIABETES MELLITUS |
1 |
0.0000 |
| 269 |
PRURITUS |
5 |
0.0000 |
| 270 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 271 |
VOMITING |
6 |
0.0000 |
| 272 |
PNEUMONIA |
4 |
0.0000 |
| 273 |
DRY MOUTH |
1 |
0.0000 |
| 274 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 275 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 276 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 277 |
TACHYCARDIA |
1 |
0.0000 |
| 278 |
CARDIAC DISORDER |
1 |
0.0000 |
| 279 |
ANXIETY |
3 |
0.0000 |
| 280 |
DYSPHAGIA |
1 |
0.0000 |
| 281 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 282 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 283 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 284 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 285 |
FLUSHING |
1 |
0.0000 |
| 286 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 287 |
ARTHRALGIA |
4 |
0.0000 |
| 288 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 289 |
INFLUENZA |
1 |
0.0000 |
| 290 |
WEIGHT INCREASED |
2 |
0.0000 |
| 291 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 292 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 293 |
PYREXIA |
3 |
0.0000 |
| 294 |
PAIN |
5 |
0.0000 |
| 295 |
DEATH |
7 |
0.0000 |
| 296 |
NEUTROPENIA |
1 |
0.0000 |
| 297 |
VISION BLURRED |
1 |
0.0000 |
| 298 |
COUGH |
2 |
0.0000 |
| 299 |
INFECTION |
1 |
0.0000 |
| 300 |
HOSPITALISATION |
1 |
0.0000 |
| 301 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 302 |
TREMOR |
1 |
0.0000 |
| 303 |
DIZZINESS |
3 |
0.0000 |
| 304 |
URTICARIA |
1 |
0.0000 |
| 305 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 306 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 307 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 308 |
COVID-19 |
1 |
0.0000 |
| 309 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 310 |
MUSCLE SPASMS |
1 |
0.0000 |
| 311 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 312 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 313 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 314 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 315 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 316 |
FALL |
1 |
0.0000 |
| 317 |
DRUG INEFFECTIVE |
3 |
0.0000 |
| 318 |
DIARRHOEA |
1 |
0.0000 |